help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-103-6-2119
Endocrinology Vol. 103, No. 6 2119-2128
Copyright © 1978 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LI, S. A.
Right arrow Articles by LI, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LI, S. A.
Right arrow Articles by LI, J. J.

Estrogen-Induced Progesterone Receptor in the Syrian Hamster Kidney. I. Modulation by Antiestrogens and Aindrogens*

SARA ANTONIA LI and JONATHAN J. LI

Research and Endocrine Services, Veterans Administration Hospital, 55417; and Departments of Pharmacology and Medicine, University of Minnesota Medical School Minneapolis, Minnesota, 55455

Address requests for reprints to: Dr. Jonathan J. Li, Veterans Administration Hospital, 54th Street and 48th Avenue South, Minneapolis, Minnesota 55417.

Abstract

Our previous studies demonstrated a specific progesterone receptor in the estrogen-induced and -dependent hamster renal carcinoma and provided evidence that estrogen treatment induces a 4S progesterone- binding component in renal cytosol of the hamster. This latter finding represented the first physiological change thus far reported during the induction period of estrogen renal tumorigenesis. The present studies indicated that the earliest appreciable increase in specific progesterone binding in kidneys of estrogen-primed hamsters occurred after 3 weeks of hormone treatment. The hormone specificity of the progesterone receptor in renal cytosol of estrogenized hamsters was ascertained by competitive binding assay and sucrose gradient centrifugation. These data indicate that the progesterone receptor is specific, since estrogens, androgens, and most progesterone metabolites did not compete appreciably for this receptor at 100-fold excess, whereas unlabeled progesterone markedly inhibited the binding at corresponding concentrations. Binding equilibrium measurements (Ka = 1.25–1.36 x 109 M-1) for the estrogeninduced progesterone receptor in the hamster kidney were similar to those obtained for the hamster uterus and renal carcinoma. Prolonged estrogen treatment did not influence the apparent minimal quantities of specific progesterone binding in hamster liver, lung, heart, or serum as well as in rat kidney. The amount of specific progesterone binding induced by estrogen in the hamster kidney (40–50 fmol/ml protein) was approximately 30 times greater than untreated levels. On the other hand, the concentration of progesterone receptor in the renal carcinoma (1,050 fmol/mg protein) is at least 520- fold higher than unprimed levels and approximately 17–20 times greater than estrogen-primed levels. Data presented herein also show that antiestrogens, such as nafoxidine and enclomiphene, but not MER-25 block the induction of specific progesterone binding by estrogen in the hamster kidney. Furthermore, androgen treatment is as effective as antiestrogens in inhibiting the increase in progesterone binding by estrogen. Similarly, hamsters previously treated with estrogen alone for 3-4 months and then subsequently treated with either nafoxidine, enclomiphene, or androgens with continued estrogen treatment resulted in the suppression of the estrogen-induced progesterone receptor response. These results are consistent with previous reports concerning the inability of estrogen to induce renal carcinoma in the hamster in the presence of antiestrogens or androgens.

Footnotes

* This work was supported by Grant CA-22008 from the National Cancer Institute, NIH, DHEW and by the General Medical Research Fund, Research Service, V.A. Hospital. It was presented in part at the 59th Annual Meeting of The Endocrine Society, Chicago, IL, June 8–10, 1977.

Received February 6, 1978.




This article has been cited by other articles:


Home page
EndocrinologyHome page
J. J. Li, S. J. Weroha, M. F. Davis, O. Tawfik, X. Hou, and S. A. Li
ER and PR in Renomedullary Interstitial Cells During Syrian Hamster Estrogen-Induced Tumorigenesis: Evidence for Receptor-Mediated Oncogenesis
Endocrinology, September 1, 2001; 142(9): 4006 - 4014.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. J. Li, X. Hou, S. K. Banerjee, D.-Z. J. Liao, F. Maggouta, J. S. Norris, and S. Antonia Li
Overexpression and Amplification of c-myc in the Syrian Hamster Kidney during Estrogen Carcinogenesis: A Probable Critical Role in Neoplastic Transformation
Cancer Res., May 1, 1999; 59(10): 2340 - 2346.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1978 by The Endocrine Society